# Antithrombin Enhancement May Improve Anticoagulation Efficiency in Infants Undergoing Cardiopulmonary Bypass for Cardiac Surgery

> **NCT01530737** · PHASE3 · COMPLETED · sponsor: **The Hospital for Sick Children** · enrollment: 18 (actual)

## Conditions studied

- Cardiopulmonary Bypass

## Interventions

- **DRUG:** Antithrombin III
- **OTHER:** Saline Placebo

## Key facts

- **NCT ID:** NCT01530737
- **Lead sponsor:** The Hospital for Sick Children
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-11
- **Primary completion:** 2014-10
- **Final completion:** 2014-10
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2015-01-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01530737

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01530737, "Antithrombin Enhancement May Improve Anticoagulation Efficiency in Infants Undergoing Cardiopulmonary Bypass for Cardiac Surgery". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01530737. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*